Agree - that has to be the most likely case... given where is it trading retained earnings will help to support the share price in terms of NTA backing anyway...
This does create a burning platform to start executing on those wonderful market opportunities they have been talking about for some time now... for us shareholders, would like to see the detail for myself - so i can decide to either cut on hold...
Ann: Acrux and Eli Lilly to appeal patent ruling on Axiron-ACR.AX, page-17
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.44M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 141351 | 6.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 73455 | 1 |
View Market Depth
| Last trade - 10.45am 10/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable